Literature DB >> 18451331

Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation.

Alexander P Reiner1, Mark M Wurfel, Leslie A Lange, Christopher S Carlson, Alex S Nord, Cara L Carty, Mark J Rieder, Cindy Desmarais, Nancy S Jenny, Carlos Iribarren, Jeremy D Walston, O Dale Williams, Deborah A Nickerson, Gail P Jarvik.   

Abstract

BACKGROUND: Circulating levels of acute phase reactant proteins such as plasma C-reactive protein (CRP) are likely influenced by multiple genes regulating the innate immune response. METHODS AND
RESULTS: We screened a set of 16 inflammation-related genes for association with CRP in a large population-based study of healthy young adults (n=1627). Results were validated in 2 independent studies (n=1208 and n=4310), including a pooled analysis of all 3 studies. In the pooled analysis, the minor allele of IL1RN 1018 (rs4251961) within the gene encoding interleukin (IL)-1 receptor antagonist (IL-1RA) was significantly associated with higher mean plasma log(CRP) level (P<1 x 10(-4)). The same IL1RN 1018 allele was associated with higher mean plasma log(IL-6) levels (P=0.004). In the pooled analysis, the minor allele of IL1RN 13888 (rs2232354) was associated with higher fibrinogen, (P=0.001). The IL1RN 1018 and 13888 variant alleles tag a clade of IL1RN haplotypes linked to allele 1 of an 86-bp VNTR polymorphism. We confirmed that the IL1RN 1018 variant (rs4251961) was associated with decreased cellular IL-1RA production ex vivo.
CONCLUSIONS: Common functional polymorphisms of the IL1RN gene are associated with several markers of systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18451331      PMCID: PMC2748384          DOI: 10.1161/ATVBAHA.108.167437

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  29 in total

1.  A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase.

Authors:  Paul Scheet; Matthew Stephens
Journal:  Am J Hum Genet       Date:  2006-02-17       Impact factor: 11.025

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

3.  IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy.

Authors:  Barbara Tolusso; Donatello Pietrapertosa; Alessia Morelli; Maria De Santis; Elisa Gremese; Giuseppina Farina; Siro Giorgio Carniello; Marino Del Frate; Gianfranco Ferraccioli
Journal:  Pharmacogenomics       Date:  2006-07       Impact factor: 2.533

4.  Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat.

Authors:  J K Tarlow; A I Blakemore; A Lennard; R Solari; H N Hughes; A Steinkasserer; G W Duff
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

5.  Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels--a study in twins.

Authors:  M A Wörns; A Victor; P R Galle; T Höhler
Journal:  Genes Immun       Date:  2006-08-10       Impact factor: 2.676

6.  Intracellular IL-1 receptor antagonist promoter: cell type-specific and inducible regulatory regions.

Authors:  J K Jenkins; R F Drong; M E Shuck; M J Bienkowski; J L Slightom; W P Arend; M F Smith
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

7.  Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells.

Authors:  M K Ganapathi; D Rzewnicki; D Samols; S L Jiang; I Kushner
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

8.  Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells.

Authors:  F Re; M Mengozzi; M Muzio; C A Dinarello; A Mantovani; F Colotta
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

9.  Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta.

Authors:  M Malyak; M F Smith; A A Abel; W P Arend
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

10.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

Authors:  Claus M Larsen; Mirjam Faulenbach; Allan Vaag; Aage Vølund; Jan A Ehses; Burkhardt Seifert; Thomas Mandrup-Poulsen; Marc Y Donath
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

View more
  35 in total

1.  Polymorphisms of interleukin-10 genes on the risk of ischemic stroke in a meta-analysis.

Authors:  Guo-Ting Yin; Yi-Tong Ma; Ying-Ying Zheng; Yi-Ning Yang; Xiao-Mei Li; Zhen-Yan Fu; Jing-Zhan Zhang; Chuan-Fang Dai; Fen Liu; Bang-Dang Chen; Min-Tao Gai; Xiang Xie
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty.

Authors:  Luigi Ferrucci; Elisa Fabbri
Journal:  Nat Rev Cardiol       Date:  2018-09       Impact factor: 32.419

Review 3.  Inflammation and the Silent Sequelae of Stroke.

Authors:  Kyra J Becker
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

4.  Genome-wide associated loci influencing interleukin (IL)-10, IL-1Ra, and IL-6 levels in African Americans.

Authors:  Fasil Tekola Ayele; Ayo Doumatey; Hanxia Huang; Jie Zhou; Bashira Charles; Michael Erdos; Jokotade Adeleye; Williams Balogun; Olufemi Fasanmade; Thomas Johnson; Johnnie Oli; Godfrey Okafor; Albert Amoah; Benjamin A Eghan; Kofi Agyenim-Boateng; Joseph Acheampong; Clement A Adebamowo; Alan Herbert; Norman Gerry; Michael Christman; Guanjie Chen; Daniel Shriner; Adebowale Adeyemo; Charles N Rotimi
Journal:  Immunogenetics       Date:  2011-12-29       Impact factor: 2.846

5.  Variable number of tandem repeat polymorphisms of the interleukin-1 receptor antagonist gene IL-1RN: a novel association with the athlete status.

Authors:  Sabina Cauci; Manuela Di Santolo; Kelli K Ryckman; Scott M Williams; Giuseppe Banfi
Journal:  BMC Med Genet       Date:  2010-02-22       Impact factor: 2.103

6.  IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist.

Authors:  Nuala J Meyer; Rui Feng; Mingyao Li; Yang Zhao; Chau-Chyun Sheu; Paula Tejera; Robert Gallop; Scarlett Bellamy; Melanie Rushefski; Paul N Lanken; Richard Aplenc; Grant E O'Keefe; Mark M Wurfel; David C Christiani; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2013-05-01       Impact factor: 21.405

7.  Stroke, IL-1ra, IL1RN, infection and outcome.

Authors:  Kyra J Becker; Dorender Dankwa; Richard Lee; Juliane Schulze; Dannielle Zierath; Patricia Tanzi; Kevin Cain; Alexander Dressel; Dean Shibata; Jonathan Weinstein
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

8.  Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion.

Authors:  Iris Steinbrugger; Anton Haas; Richard Maier; Wilfried Renner; Monika Mayer; Christoph Werner; Andreas Wedrich; Yosuf El-Shabrawi; Otto Schmut; Martin Weger
Journal:  Mol Vis       Date:  2009-03-27       Impact factor: 2.367

9.  Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

Authors:  Claus M Larsen; Mirjam Faulenbach; Allan Vaag; Jan A Ehses; Marc Y Donath; Thomas Mandrup-Poulsen
Journal:  Diabetes Care       Date:  2009-06-19       Impact factor: 19.112

10.  Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations.

Authors:  Mukundan Attur; Hwa-Ying Wang; Virginia Byers Kraus; Jack F Bukowski; Nazneen Aziz; Svetlana Krasnokutsky; Jonathan Samuels; Jeffrey Greenberg; Gary McDaniel; Steven B Abramson; Kenneth S Kornman
Journal:  Ann Rheum Dis       Date:  2009-11-23       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.